Inventor
KWOK-KIN WONG
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms11%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C07KPeptides5%
PatentTitleYear
12,336,988Therapeutic targeting of 202511,944,615Combination therapy for treatment of LKB1 deficient cancers202411,865,176Compositions and methods of modulating anti-tumor immunity202411,624,093Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response202311,446,309Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors202211,298,354Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhibitors202211,236,082EZH2 inhibitors and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to DANA FARBER CANCER INST INC (5)· patent assignee history
2022Patents assigned to ACETYLON PHARMACEUTICALS INC (1)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to CHILDRENS MEDICAL CENTER (1)· patent assignee history
2024–2025Patents assigned to UNIV NEW YORK (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DANA FARBER CANCER INST INC | 5 | 2022–2024 |
| UNIV NEW YORK | 2 | 2024–2025 |
| ACETYLON PHARMACEUTICALS INC | 1 | 2022 |
| CHILDRENS MEDICAL CENTER | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |